Jakafi (ruxolitinib) - Incyte
Peri-transplant ruxolitinib in myelofibrosis patients undergoing αβTCR and CD19-depleted stem cell transplantation. (PubMed, Bone Marrow Transplant) - Oct 7, 2026 - No abstract available 
Journal • Myelofibrosis • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/42839031
 
Anke Janssen; Anna van Rhenen; Anniek Stuut; Christien Oudbier; Flores Weverling; Frances Verheij; Iris Brinkman; Julia Drylewicz; Jurgen Kuball; Kasper Westinga; Klaartje Nijssen; Laura Daenen; Lisette van de Corput; Lotte van der Wagen; Moniek de Witte; Pleun Schonewille; Reinier Raymakers; Tim Hutten
 
Oct 7, 2026
 
Prev Next